Phase II study of oral vinorelbine in combination with carboplatin followed by consolidation therapy with oral vinorelbine as single-agent in unresectable localized or metastatic non-small cell lung carcinoma-Reference-Cited by-同舟云学术

Phase II study of oral vinorelbine in combination with carboplatin followed by consolidation therapy with oral vinorelbine as single-agent in unresectable localized or metastatic non-small cell lung carcinoma

Published:2009-06 Issue:3 Volume:64 Page:319-325
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Reck Martin,Macha Hans-Nikol,Del Barco Sonia,Cornes Paul,Vaissière Nathalie,Morand Maryse,Riggi Marcello,Abratt Raymond

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference34 articles.

1. Cancer statistics;Jemal;CA Cancer J Clin,2007

2. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials;BMJ,1995

3. Treatment of Unresectable Non-Small-Cell Lung Cancer Guideline: Update 2003;Pfister;J Clin Oncol,2004

4. Cancer principles and practice of oncology,1997

5. Randomized, Multinational, phase III study of Docetaxel plus platinum combinations versus Vinorelbine plus Cisplatin for advanced non-small cell lung cancer: The TAX 326 Study Group;Fossella;JCO,2003

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03);Therapeutic Advances in Medical Oncology;2021-01

2. Vinorelbine in Non-Small Cell Lung Cancer: Real-World Data From a Single-Institution Experience;Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics;2020-05-29

3. Oral Chemotherapy for Treatment of Lung Cancer;Frontiers in Oncology;2020-04-28

4. Oral vinorelbine: a narrative review;Cancer Nursing Practice;2018-03-08

5. Efficacy of Metronomic Vinorelbine in Elderly Patients with Advanced Non-Small-Cell Lung Cancer and Poor Performance Status;Current Oncology;2017-06-01